MNOV Medicinova Inc

Price (delayed)

$3.03

Market cap

$148.6M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.22

Enterprise value

$73.73M

MediciNova, Inc. is a publicly-traded biopharmaceutical company founded upon developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a primary commercial focus on the U.S. ...

Highlights
MNOV's EPS is up by 21% year-on-year and by 4.3% since the previous quarter
MNOV's net income is up by 14% YoY
The equity is up by 18% year-on-year but it has declined by 3.1% since the previous quarter
The quick ratio has contracted by 48% YoY and by 43% from the previous quarter

Key stats

What are the main financial stats of MNOV
Market
Shares outstanding
49.04M
Market cap
$148.6M
Enterprise value
$73.73M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.72
Price to sales (P/S)
36.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.26
Earnings
Revenue
$4.04M
EBIT
-$11.04M
EBITDA
-$10.85M
Free cash flow
-$7.75M
Per share
EPS
-$0.22
Free cash flow per share
-$0.16
Book value per share
$1.77
Revenue per share
$0.08
TBVPS
$1.67
Balance sheet
Total assets
$91.62M
Total liabilities
$5.14M
Debt
$150,682
Equity
$86.48M
Working capital
$71.96M
Liquidity
Debt to equity
0
Current ratio
18.12
Quick ratio
17.85
Net debt/EBITDA
6.9
Margins
EBITDA margin
-268.7%
Gross margin
100%
Net margin
-273.3%
Operating margin
-276%
Efficiency
Return on assets
-12.4%
Return on equity
-13%
Return on invested capital
-233.4%
Return on capital employed
-12.6%
Return on sales
-273.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MNOV stock price

How has the Medicinova stock price performed over time
Intraday
-7.62%
1 week
-15.13%
1 month
-12.17%
1 year
-49.5%
YTD
-42.4%
QTD
-20.05%

Financial performance

How have Medicinova's revenue and profit performed over time
Revenue
$4.04M
Gross profit
$4.04M
Operating income
-$11.14M
Net income
-$11.04M
Gross margin
100%
Net margin
-273.3%
The operating income is up by 17% year-on-year
MNOV's net income is up by 14% YoY
MNOV's operating margin is up by 2% QoQ
The net margin has grown by 2% from the previous quarter

Growth

What is Medicinova's growth rate over time

Valuation

What is Medicinova stock price valuation
P/E
N/A
P/B
1.72
P/S
36.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.26
MNOV's EPS is up by 21% year-on-year and by 4.3% since the previous quarter
The P/B is 62% lower than the 5-year quarterly average of 4.5 and 34% lower than the last 4 quarters average of 2.6
The equity is up by 18% year-on-year but it has declined by 3.1% since the previous quarter

Efficiency

How efficient is Medicinova business performance
MNOV's ROIC is up by 31% YoY but it is down by 6% QoQ
Medicinova's return on equity has increased by 26% YoY and by 5% QoQ
The ROA rose by 25% YoY and by 4.6% QoQ
MNOV's return on sales is up by 2% since the previous quarter

Dividends

What is MNOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MNOV.

Financial health

How did Medicinova financials performed over time
The quick ratio has contracted by 48% YoY and by 43% from the previous quarter
MNOV's current ratio is down by 48% year-on-year and by 43% since the previous quarter
The debt is 100% less than the equity
The equity is up by 18% year-on-year but it has declined by 3.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.